| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4023511 | Journal Français d'Ophtalmologie | 2014 | 7 Pages |
Abstract
This study did not show a statistically significant change in the incidence of SRH after intravitreal anti-VEGF therapy. The benefit/risk ratio of intravitreal anti-VEGF injections for exudative AMD remains high.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Y. Kauffmann, R. Isaico, A. Lefebvre, A.M. Bron, C. Creuzot-Garcher,